|
|
Article: Ipsos PharmTrends Examines the Return On Investment for Prescription Drug Samples.
- Article from:
- Business Wire
- Article date:
- August 27, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
PORT WASHINGTON, N.Y.--(BW HealthWire)--Aug. 27, 2001
New Syndicated Marketing Tool Helps Manufacturers Measure the
Effectiveness of Drug Samples for Generating Prescriptions
A new syndicated tool from leading market research firm, Ipsos-NPD, Inc., Ipsos PharmTrends(R) Drug Sample ROI Report, (Ipsos PharmTrends ROI Report) measures the effectiveness of prescription drug samples in promoting sales of new and established drugs to prospective customers.
Half of all promotional dollars spent by drug manufacturers are allocated to the production and distribution of samples. Are these dollars ...